Physicians wrestled with endpoint composition, low event rates, a possible difference in ischemic strokes, and more.

Boston Scientific (NYSE:BSX) announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.

Study suggests a path forward for device therapy, though caveats are plenty ...

SYRACUSE, N.Y. (WSYR-TV) — A Central New York man is sharing his story after decades of heart issues, and how a small device is helping protect his life. Simply being here today means everything for ...

St. Joseph's Health is celebrating a major milestone, after recently completing its 1,000th WATCHMAN procedure. Shoppers alarmed by what's happening at malls: "Living in hell" Rescuers respond to ...

Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary safety and efficacy endpoints. The study evaluated the WATCHMAN FLX™ ...

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

AFib, an irregular and often very fast heart rhythm, can lead to blood clots in the heart and significantly increase the ...

In patients with atrial fibrillation, those assigned left atrial appendage closure had similar ischemic outcomes and better bleeding outcomes compared with those assigned oral anticoagulation, ...

For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...

The suit was filed by Spykar Lifestyles seeking recovery of ₹87 lakh with interest based on a lease deed executed between the ...

INDORE: Eighteen-year-old Mohnish, who ploughed his car through a group of residents leading to death of a woman at Shiv ...